心力衰竭患者血运重建:CABG与PCI的仿真随机对照试验
该研究利用英格兰常规收集的医疗数据构建仿真临床试验,比较冠状动脉旁路移植术(CABG)与复杂经皮冠状动脉介入(PCI)在心力衰竭患者中的效果。结论提示CABG与5年死亡或心血管住院减少相关,需前瞻性试验验证。
要点
- 仿真试验提示CABG较复杂PCI降低5年死亡或心血管住院风险。
- 主要分析采用工具变量法,ATE为16.2(95%CI 20.6至11.8)。
- 结果在未匹配目标人群中一致(ATE 15.5,95%CI 17.5至13.5)。
核心结论
- 在心力衰竭患者中,仿真模型提示CABG与5年死亡或心血管住院减少相关。
研究设计与样本
- 通过匹配外科治疗缺血性心力衰竭(STICH)试验个体数据,仿真队列纳入2046例患者。
主要发现
- 未调整主要结局发生率在CABG组为51.1,PCI组为70.0。
- 工具变量分析显示CABG与较低主要结局风险相关(ATE 16.2,95%CI 20.6至11.8)。
- 未匹配目标人群估计一致(ATE 15.5,95%CI 17.5至13.5)。
临床怎么用
- 对于心衰合并缺血性左室功能不全患者,CABG可能优于复杂PCI,但需前瞻性试验确认。
局限性
- 仿真模型结果需前瞻性随机试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The choice of revascularization with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in people with ischaemic left ventricular dysfunction is not guided by high-quality evidence. METHODS AND RESULTS: A trial of CABG vs. PCI in people with heart failure (HF) was modelled in silico using routinely collected healthcare data. The in silico trial cohort was selected by matching the target trial cohort, identified from Hospital Episode Statistics in England, with individual patient data from the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Allocation to CABG vs. complex PCI demonstrated random variation across administrative regions in England and was a valid statistical instrument. The primary outcome was 5-year all-cause mortality or cardiovascular hospitalization. Instrumental variable analysis (IVA) was used for the primary analysis. Results were expressed as average treatment effects (ATEs) with 95 confidence intervals (CIs). The target population included 13 519 HF patients undergoing CABG or complex PCI between April 2009 and March 2015. After matching, the emulated trial cohort included 2046 patients. The unadjusted primary outcome rate was 51.1 in the CABG group and 70.0 in the PCI group. IVA of the emulated cohort showed that CABG was associated with a lower risk of the primary outcome (ATE 16.2, 95 CI 20.6 to 11.8), with comparable estimates in the unmatched target population (ATE 15.5, 95 CI 17.5 to 13.5). CONCLUSION: In people with HF, in silico modelling suggests that CABG is associated with fewer deaths or cardiovascular hospitalizations at 5 years vs. complex PCI. A pragmatic clinical trial is needed to test this hypothesis and this trial would be feasible.
引用
- Pathak, Lai, Miksza, et al. Surgical or percutaneous coronary revascularization for heart failure: an in silico model using routinely collected health data to emulate a clinical trial. Eur Heart J. 2023. PMID: 36350978. doi:10.1093/eurheartj/ehac670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。